Skip to main content

Table 2 Genotype and allele frequencies of CLU rs2279590 C/T, rs11136000 C/T, rs1532278 C/T, and rs3087554 T/C SNPs in patients with PEG, patients with PEX, and the controls

From: Influence of clusterin genetic variants on IOP elevation in pseudoexfoliation syndrome and pseudoexfoliative glaucoma in Turkish population

SNP

Genotypes/Alleles

PEG (n = 239)

PEX (n = 240)

Control (n = 240)

Genetic model

Adjusted OR (95% CI)

P

rs2279590 C/T

Genotypes, n (%)

   

Recessive

0.88a (0.56–1.38) 0.84b (0.54–1.33) 1.10c (0.69–1.76)

.570a .460b .690c

CC

97 (40.6)

86 (35.8)

92 (38.3)

 

CT

97 (40.6)

110 (45.8)

97 (40.4)

Dominant

0.94a (0.65–1.36) 1.12b (0.77–1.62) 0.84c (0.58–1.21)

.730a .550b .340c

TT

45 (18.8)

44 (18.3)

51 (21.2)

 

Alleles, n (%)

C

291 (60.9)

282 (58.8)

281 (58.5)

 

0.91a (0.70–1.18) 0.99b (0.77–1.28) 0.92c (0.71–1.19)

.460a > .999 .500c

T

187 (39.1)

198 (41.2)

199 (41.5)

 

rs11136000 C/T

Genotypes, n (%)

   

Recessive

0.78a (0.49–1.22) 0.77b (0.49–1.22) 1.06c (0.66–1.71)

.270a .270b .810c

CC

99 (41.4)

91 (37.9)

92 (38.3)

 

CT

98 (41.0)

107 (44.6)

96 (40.0)

Dominant

0.92a (0.63–1.32) 1.02b (0.71–1.48) 0.88c (0.61–1.27)

.640a .900b .490c

TT

42 (17.6)

42 (17.5)

52 (21.7)

 

Alleles, n (%)

C

296 (61.9)

289 (60.2)

280 (58.3)

 

0.86a (0.66–1.12) 0.93b (0.72–1.20) 0.93c (0.72–1.21)

.260a .550b .590c

T

182 (38.1)

191 (39.8)

200 (41.7)

 

rs1532278 C/T

Genotypes, n (%)

   

Recessive

0.80a (0.51–1.26) 0.79b (0.50–1.25) 1.06c (0.66–1.71)

.340a .320b .800c

CC

99 (41.4)

91 (37.9)

93 (38.8)

 

CT

98 (41.0)

107 (44.6)

96 (40.0)

Dominant

0.93a (0.64–1.34) 1.04b (0.72–1.50) 0.88c (0.61–1.27)

.680a .840b .490c

TT

42 (17.6)

42 (17.5)

51 (21.2)

 

Alleles, n (%)

C

296 (61.9)

289 (60.2)

282 (58.8)

 

0.88a (0.68–1.14) 0.94b (0.73–1.22) 0.93c (0.72–1.21)

.320a .650b .590c

T

182 (38.1)

191 (39.8)

198 (41.2)

 

rs3087554 T/C

Genotypes, n (%)

   

Recessive

1.65a (0.57–4.76) 2.43b (0.92–6.44) 0.63c (0.27–1.49)

.350a .060b .290c

TT

166 (69.5)

170 (70.8)

180 (75.0)

 

TC

64 (26.8)

56 (23.3)

54 (22.5)

Dominant

1.33a (0.89–2.00) 1.23b (0.82–1.84) 1.06c (0.71–1.56)

.160a .320b .790c

CC

9 (3.8)

14 (5.8)

6 (2.5)

 

Alleles, n (%)

T

396 (82.8)

396 (82.5)

414 (86.2)

 

1.30a (0.91–1.85) 1.33b (0.94–1.89) 0.98c (0.70–1.36)

.140a .110b  > .999c

C

82 (17.2)

84 (17.5)

66 (13.8)

 
  1. OR  Odds ratio, CI  Cnfidence interval,  Cytosine,  Thymine. a PEG vs. Control, b PEX vs. Control, c PEG vs. PEX. Age- and sex-corrected OR, CI and P values for genotypes were calculated using SNPstats web tool. Recessive model; TT vs. CT + CC for rs2279590 C/T, rs11136000 C/T, rs1532278 C/T; CC vs. TC + TT for rs3087554 T/C; Dominant model; TT + CT vs. CC rs2279590 C/T, rs11136000 C/T, rs1532278 C/T;CC + TC vs. TT for rs3087554 T/C. OR, CI and P value for the allele frequency was calculated using the χ2 test as T vs. C for rs2279590 C/T, rs11136000 C/T, rs1532278 C/T and C vs. T for rs3087554 T/C. Bonferroni corrected significance cut-off value was .01 for genotypes, and .017 for allele frequency